• SHANKHADIP NANDI Department of Pharmaceutics, Gitanjali College of Pharmacy, Birbhum, West Bengal, India.


3D printing technology is a rapid prototyping process based on computer-aided design software that is proficient to construct solid objects with various geometrics by depositing numerous layers in a sequence. The major advantages of three-dimensional printing (3DP) technology over the traditional manufacturing of pharmaceuticals include the customization of medications with individually adjusted doses, on-demand tailored manufacturing, unprecedented flexibility in the design, manufacturing of complex and sophisticated solid dosage forms, and economic benefits. Recently, many researchers have been invested their efforts in applying 3DP technology to the pharmaceutical development of drug products and different drug delivery systems. Selective laser sintering, fused deposition modeling, semi-solid extrusion, stereolithography, etc., are the multiple 3DP technologies that can be established in several customized and programmable medicines. Sublingual, orodispersible, and fast-dissolving drug delivery formulations by 3DP technology have been already manufactured. Controlled-release formulations with different characteristics, doughnut-shaped multi-layered tablets with linear release kinetics, and drug-loaded tablets with modified-release characteristics are recently fabricated using 3DP. However, few 3DP methods produce uneven shapes of dosage forms and comparatively porous structures. Cost of transition, adaptation to the existing facility, achieving regulatory approval, etc., are the present challenges that can restrict the extensive application of 3DP technology to pharmaceutical products. Intense research work for modifying the 3DP methods is simultaneously sustained for by-passing the flaws and current limitations of this technology. 3DP technology can act as a convenient and potential tool for the pharmaceutical industry which will set a revolutionary manufacturing style in the near future to facilitate patient-centered health care.

Keywords: Computer-aided design, Three-dimensional printing, Stereolithography, Orodispersible, Fused deposition modeling, Linear release kinetics


1. Maroni A, Melocchi A, Parietti F, Foppoli A, Zema L, Gazzaniga A. 3D printed multi-compartment capsular devices for two-pulse oral drug delivery. J Control Release 2017;268:10-8.
2. Norman J, Madurawe RD, Moore CM, Khan MA, Khairuzzaman A. A new chapter in pharmaceutical manufacturing: 3D-printed drug products. Adv Drug Deliv Rev 2017;108:39-50.
3. Karri SR, Reddy VV, Radhakrishna K, Ganesh GN. Development of osmotically controlled oral drug delivery system for nateglinide an anti-diabetic drug. Int J Pharm Pharm Sci 2014;6:120-25.
4. Jamróz W, Szafraniec J, Kurek M, Jachowicz R. 3D printing in pharmaceutical and medical applications-recent achievements and challenges. Pharm Res 2018;35:176.
5. Ursan ID, Chiu L, Pierce A. Three-dimensional drug printing: A structured review. J Am Pharm Assoc 2013;53:136-44.
6. Jun XY, Yan W, Qiang W, Qi WC, Zhong HX, Fen Z, et al. Structural broadband absorbing metamaterial based on three-dimensional printing technology. Acta Phys Sin 2018;67:084202.
7. Goole J, Amighi K. 3D printing in pharmaceutics: A new tool for designing customized drug delivery systems. Int J Pharm 2016;499:376-94.
8. Tofail SA, Koumoulos EP, Bandyopadhyay A, Bose S, O’Donoghue L, Charitidis C. Additive manufacturing: Scientific and technological challenges, market uptake and opportunities. Mater Today 2017;21:22-37.
9. Mannan A, Mubeen H. Digitalisation and automation in pharmaceuticals from drug discovery to drug administration. Int J Pharm Pharm Sci 2018;10:1-10.
10. Chia HN, Wu BM. Recent advances in 3D printing of biomaterials. J Biol Eng 2015;9:4.
11. Liaw CY, Guvendiren M. Current and emerging applications of 3D printing in medicine. Biofabrication 2017;9:024102.
12. Maulvi FA, Shah MJ, Solanki BS, Patel AS, Soni TG, Shah DO. Application of 3D printing technology in the development of novel drug delivery systems. Int J Drug Dev Res 2017;9:44-9.
13. Peng W, Datta P, Ayan B, Ozbolat V, Sosnoski D, Ozbolat IT. 3D bioprinting for drug discovery and development in pharmaceutics. Acta Biomater 2017;57:26-46.
14. Jose PA, Christoper PG. 3D printing of pharmaceuticals-a potential technology in developing personalized medicine. Asian J Pharm Res Dev 2018;6:46-54.
15. Kumar AE, Devi GC, Sharada N. A review on novel approach to pharmaceutical drug delivery: 3D printing. Int J Pharm Sci Res 2019;10:1575-81.
16. Wang J, Goyanes A, Gaisford S, Basit AW. Stereolithographic (SLA) 3D printing of oral modified-release dosage forms. Int J Pharm 2016;503:207-12.
17. Yu DG, Branford-White C, Ma ZH, Zhu LM, Li XY, Yang XL. Novel drug delivery devices for providing linear release profiles fabricated by 3DP. Int J Pharm 2009;370:160-6.
18. Goyanes A, Buanz AB, Hatton GB, Gaisford S, Basit AW. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets. Eur J Pharm Biopharm 2015;89:157-62.
19. Fu J, Yu X, Jin Y. 3D printing of vaginal rings with personalized shapes for controlled release of progesterone. Int J Pharm 2018;539:75-82.
20. Goyanes A, Chang H, Sedough D, Hatton GB, Wang J, Buanz A, et al. Fabrication of controlled-release budesonide tablets via desktop (FDM) 3D printing. Int J Pharm 2015;496:414-20.
21. Goyanes A, Fina F, Martorana A, Sedough D, Gaisford S, Basit AW. Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing. Int J Pharm 2017;527:21-30.
22. Li Q, Wen H, Jia D, Guan X, Pan H, Yang Y, et al. Preparation and investigation of controlled-release glipizide novel oral device with three-dimensional printing. Int J Pharm 2017;525:5-11.
23. Siyawamwaya M, Toit LC, Kumar P, Choonara YE, Kondiah PP, Pillay V. 3D printed, controlled release, tritherapeutic tablet matrix for advanced anti-HIV-1 drug delivery. Eur J Pharm Biopharm 2019;138:99-110.
24. Sun Y, Soh S. Printing tablets with fully customizable release profiles for personalized medicine. Adv Mater 2015;27:7847-53.
25. Alhnan MA, Okwuosa TC, Sadia M, Wan KW, Ahmed W, Arafat B. Emergence of 3D printed dosage forms: Opportunities and challenges. Pharm Res 2016;33:1817-32.
26. Katakam P, Dey B, Assaleh FH, Hwisa NT, Adiki SK, Chandu BR, et al. Top-down and bottom-up approaches in 3D printing technologies for drug delivery challenges. Crit Rev Ther Drug Carrier Syst 2015;32:61-87.
27. Ventola CL. Medical applications for 3D printing: Current and projected uses. Pharm Ther 2014;39:704-11.
28. Khaled SA, Burley JC, Alexander MR, Roberts CJ. Desktop 3D printing of controlled release pharmaceutical bilayer tablets. Int J Pharm 2014;461:105-11.
29. Katstra WE, Palazzolo RD, Rowe CW, Giritlioglu B, Teung P, Cima MJ. Oral dosage forms fabricated by three dimensional printing. J Control Release 2000;66:1-9.
30. Jassim-Jaboori AH, Oyewumi MO. 3D printing technology in pharmaceutical drug delivery: Prospects and challenges. J Biomol Res Ther 2015;4:e141.
31. Meléndez PA, Kane KM, Ashvar CS, Albrecht M, Smith PA. Thermal inkjet application in the preparation of oral dosage forms: Dispensing of prednisolone solutions and polymorphic characterization by solid-state spectroscopic techniques. J Pharm Sci 2008;97:2619-36.
32. Konta AA, Garcia-Piña M, Serrano DR. Personalised 3D printed medicines: Which techniques and polymers are more successful? Bioengineering 2017;4:79-94.
33. de Gans BJ, Duineveld PC, Schubert US. Inkjet printing of polymers: State of the art and future developments. Adv Mater 2004;16:203-13.
34. Gross BC, Erkal JL, Lockwood SY, Chen C, Spence DM. Evaluation of 3D printing and its potential impact on biotechnology and the chemical sciences. Anal Chem 2014;86:3240-53.
35. Park BJ, Choi HJ, Moon SJ, Kim SJ, Bajracharya R, Min JY, et al. Pharmaceutical applications of 3D printing technology: Current understanding and future perspectives. J Pharm Investig 2019;49:575-85.
36. Sumerel J, Lewis J, Doraiswamy A, Deravi LF, Sewell SL, Gerdon AE, et al. Piezoelectric ink jet processing of materials for medical and biological applications. Biotechnol J 2006;1:976-87.
37. Lee BK, Yun YH, Choi JS, Choi YC, Kim JD, Cho YW. Fabrication of drug-loaded polymer microparticles with arbitrary geometries using a piezoelectric inkjet printing system. Int J Pharm 2012;427:305-10.
38. Dimitrov D, Schreve K, de Beer N. Advances in three dimensional printing-state of the art and future perspectives. Rapid Prototyp J 2006;12:136-47.
39. Vaezi M, Seitz H, Yang S. A review on 3D micro-additive manufacturing technologies. Int J Adv Manuf Technol 2013;67:1721-54.
40. Alhijjaj M, Belton P, Qi S. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing. Eur J Pharm Biopharm 2016;108:111-25.
41. Mathew E, Pitzanti G, Larrañeta E, Lamprou DA. 3D printing of pharmaceuticals and drug delivery devices. Pharmaceutics 2020;12:266.
42. Masood SH. Application of fused deposition modelling in controlled drug delivery devices. Assem Autom 2007;27:215-21.
43. Giri BR, Song ES, Kwon J, Lee JH, Park JB, Kim DW. Fabrication of intragastric floating, controlled release 3D printed theophylline tablets using hot-melt extrusion and fused deposition modeling. Pharmaceutics 2020;12:77.
44. Stewart SA, Domínguez-Robles J, Mcilorum, VJ, Mancuso E, Lamprou DA, Donnelly RF, et al. Development of a biodegradable subcutaneous implant for prolonged drug delivery using 3D printing. Pharmaceutics 2020;12:105.
45. Lamichhane S, Park JB, Sohn DH, Lee S. Customized novel design of 3D printed pregabalin tablets for intra-gastric floating and controlled release using fused deposition modeling. Pharmaceutics 2019;11:564.
46. Dumpa NR, Bandari S, Repka MA. Novel gastroretentive floating pulsatile drug delivery system produced via hot-melt extrusion and fused deposition modeling 3D printing. Pharmaceutics 2020;12:52.
47. Alhijjaj M, Nasereddin J, Belton P, Qi S. Impact of processing parameters on the quality of pharmaceutical solid dosage forms produced by fused deposition modeling (FDM). Pharmaceutics 2019;11:633.
48. Domínguez-Robles J, Mancinelli C, Mancuso E, García-Romero I, Gilmore BF, Casettari L, et al. 3D printing of drug-loaded thermoplastic polyurethane meshes: A potential material for soft tissue reinforcement in vaginal surgery. Pharmaceutics 2020;12:63.
49. Tidau M, Kwade A, Finke JH. Influence of high, disperse API load on properties along the fused-layer modeling process chain of solid dosage forms. Pharmaceutics 2019;11:194.
50. Arany P, Róka E, Mollet L, Coleman AW, Perret F, Kim B, et al. Fused deposition modeling 3D printing: Test platforms for evaluating post-fabrication chemical modifications and in-vitro biological properties. Pharmaceutics 2019;11:277.
51. Domínguez-Robles J, Martin NK, Fong ML, Stewart SA, Irwin NJ, Rial-Hermida MI, et al. Antioxidant PLA composites containing lignin for 3D printing applications: A potential material for healthcare applications. Pharmaceutics 2019;11:165.
52. Chew SL, de Mohac LM, Raimi-Abraham BT. 3D-printed solid dispersion drug products. Pharmaceutics 2019;11:672.
53. Vozzi G, Flaim C, Ahluwalia A, Bhatia S. Fabrication of PLGA scaffolds using soft lithography and microsyringe deposition. Biomaterials 2003;24:2533-40.
54. Tirella A, Vozzi F, Vozzi G, Ahluwalia A. PAM2 (piston assisted microsyringe): A new rapid prototyping technique for biofabrication of cell incorporated scaffolds. Tissue Eng Part C Methods 2010;17:229-37.
55. Shende P, Agrawal S. Integration of 3D printing with dosage forms: A new perspective for modern healthcare. Biomed Pharmacother 2018;107:146-54.
56. Healy AV, Fuenmayor E, Doran P, Geever LM, Higginbotham CL, Lyons JG. Additive manufacturing of personalized pharmaceutical dosage forms via stereolithography. Pharmaceutics 2019;11:645.
57. Melchels FP, Feijen J, Grijpma DW. A review on stereolithography and its applications in biomedical engineering. Biomaterials 2010;31:6121-30.
58. Robles-Martinez P, Xu X, Trenfield SJ, Awad A, Goyanes A, Telford R, et al. 3D printing of a multi-layered polypill containing six drugs using a novel stereolithographic method. Pharmaceutics 2019;11:274.
59. Kim K, Han S, Yoon J, Kwon S, Park HK, Park W. Lithographic resolution enhancement of a maskless lithography system based on a wobulation technique for flow lithography. Appl Phys Lett 2016;109:234101.
60. Madzarevic M, Medarevic D, Vulovic A, Sustersic T, Djuris J, Filipovic N, et al. Optimization and prediction of ibuprofen release from 3D DLP printlets using artificial neural networks. Pharmaceutics 2019;11:544.
61. Awad A, Fina F, Trenfield SJ, Patel P, Goyanes A, Gaisford S, et al. 3D printed pellets (miniprintlets): A novel, multi-drug, controlled release platform technology. Pharmaceutics 2019;11:148.
62. Bikas H, Stavropoulos P, Chryssolouris G. Additive manufacturing methods and modelling approaches: A critical review. Int J Adv Manuf Technol 2016;83:389-405.
63. Kondiah PJ, Kondiah PP, Choonara YE, Marimuthu T, Pillay V. A 3D bioprinted pseudo-bone drug delivery scaffold for bone tissue engineering. Pharmaceutics 2020;12:166.
64. Andriotis EG, Eleftheriadis GK, Karavasili C, Fatouros DG. Development of bio-active patches based on pectin for the treatment of ulcers and wounds using 3D-bioprinting technology. Pharmaceutics 2020;12:56.
65. Rycerz K, Stepien KA, Czapiewska M, Arafat BT, Habashy R, Isreb A, et al. Embedded 3D printing of novel bespoke soft dosage form concept for pediatrics. Pharmaceutics 2019;11:630.
66. Goyanes A, Kobayashi M, Martínez-Pacheco R, Gaisford S, Basit AW. Fused-filament 3D printing of drug products: Microstructure analysis and drug release characteristics of PVA-based caplets. Int J Pharm 2016;514:290-5.
67. Okwuosa TC, Stefaniak D, Arafat B, Isreb A, Wan KW, Alhnan MA. A lower temperature FDM 3D printing for the manufacture of patient-specific immediate release tablets. Pharm Res 2016;33:2704-12.
68. Sadia M, So?nicka A, Arafat B, Isreb A, Ahmed W, Kelarakis A, et al. Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets. Int J Pharm 2016;513:659-68.
69. Khaled SA, Alexander MR, Wildman RD, Wallace MJ, Sharpe S, Yoo J, et al. 3D extrusion printing of high drug loading immediate release paracetamol tablets. Int J Pharm 2018;538:223-30.
70. Pietrzak K, Isreb A, Alhnan MA. A flexible-dose dispenser for immediate and extended release 3D printed tablets. Eur J Pharm Biopharm 2015;96:380-87.
71. Skowyra J, Pietrzak K, Alhnan MA. Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing. Eur J Pharm Sci 2015;68:11-7.
72. Wang CC, Motwani MR, Roach WJ, Kay JL, Yoo J, Surprenant HL, et al. Development of near zero-order release dosage forms using three-dimensional printing (3-DP) technology. Drug Dev Ind Pharm 2006;32:367-76.
73. Genina N, Boetker JP, Colombo S, Harmankaya N, Rantanen J, Bohr A. Anti-tuberculosis drug combination for controlled oral delivery using 3D printed compartmental dosage forms: From drug product design to in vivo testing. J Control Release 2017;268:40-8.
74. Yu DG, Yang XL, Huang WD, Liu J, Wang YG, Xu H. Tablets with material gradients fabricated by three-dimensional printing. J Pharm Sci 2007;96:2446-56.
75. Li Q, Guan X, Cui M, Zhu Z, Chen K, Wen H, et al. Preparation and investigation of novel gastro-floating tablets with 3D extrusion-based printing. Int J Pharm 2018;535:325-32.
76. Clark EA, Alexander MR, Irvine DJ, Roberts CJ, Wallace MJ, Sharpe S, et al. 3D printing of tablets using inkjet with UV photoinitiation. Int J Pharm 2017;529:523-30.
77. Goyanes A, Buanz AB, Basit AW, Gaisford S. Fused-filament 3D printing (3DP) for fabrication of tablets. Int J Pharm 2014;476:88-92.
78. Khaled SA, Burley JC, Alexander MR, Yang J, Roberts CJ. 3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles. J Control Release 2015;217:308-14.
79. Khaled SA, Burley JC, Alexander MR, Yang J, Roberts CJ. 3D printing of tablets containing multiple drugs with defined release profiles. Int J Pharm 2015;494:643-50.
80. Kyobula M, Adedeji A, Alexander MR, Saleh E, Wildman R, Ashcroft I. 3D inkjet printing of tablets exploiting bespoke complex geometries for controlled and tuneable drug release. J Control Release 2017;261:207-15.
81. Okwuosa TC, Pereira BC, Arafat B, Cieszynska M, Isreb A, Alhnan MA. Fabricating a shell-core delayed release tablet using dual FDM 3D printing for patient-centred therapy. Pharm Res 2017;34:427-37.
82. Rowe CW, Katstra WE, Palazzolo RD, Giritlioglu B, Teung P, Cima MJ. Multimechanism oral dosage forms fabricated by three dimensional printing. J Control Release 2000;66:11-7.
83. Jamróz W, Kurek M, ?yszczarz E, Szafraniec J, Knapik-Kowalczuk J, Syrek K, et al. 3D printed orodispersible films with aripiprazole. Int J Pharm 2017;533:413-20.
84. Solanki NG, Tahsin M, Shah AV, Serajuddin AT. Formulation of 3D printed tablet for rapid drug release by fused deposition modeling: Screening polymers for drug release, drug-polymer miscibility and printability. J Pharm Sci 2018;107:390-401.
85. Musazzi UM, Selmin F, Ortenzi MA, Mohammed GK, Franzé S, Minghetti P, et al. Personalized orodispersible films by hot melt ram extrusion 3D printing. Int J Pharm 2018;551:52-9.
86. Kempin W, Domsta V, Grathoff G, Brecht I, Semmling B, Tillmann S, et al. Immediate release 3D-printed tablets produced via fused deposition modeling of a thermo-sensitive drug. Pharm Res 2018;35:124.
87. Yi HG, Choi YJ, Kang KS, Hong JM, Pati RG, Park MN, et al. A 3D-printed local drug delivery patch for pancreatic cancer growth suppression. J Control Release 2016;238:231-41.
88. Huang W, Zheng Q, Sun W, Xu H, Yang X. Levofloxacin implants with predefined microstructure fabricated by three-dimensional printing technique. Int J Pharm 2007;339:33-8.
89. Wu W, Zheng Q, Guo X, Sun J, Liu Y. A programmed release multi-drug implant fabricated by three-dimensional printing technology for bone tuberculosis therapy. Biomed Mater 2009;4:065005.
90. Wu W, Ye C, Zheng Q, Wu G, Cheng Z. A therapeutic delivery system for chronic osteomyelitis via a multi-drug implant based on three-dimensional printing technology. J Biomater Appl 2016;31:250-60.
91. Ahlfeld T, Akkineni AR, Förster Y, Köhler T, Knaack S, Gelinsky M, et al. Design and fabrication of complex scaffolds for bone defect healing: Combined 3D plotting of a calcium phosphate cement and a growth factor-loaded hydrogel. Ann Biomed Eng 2017;45:224-36.
92. Johnson AR, Caudill CL, Tumbleston JR, Bloomquist CJ, Moga KA, Ermoshkin A, et al. Single-step fabrication of computationally designed microneedles by continuous liquid interface production. PLoS One 2016;11:e0162518.
93. Lu Y, Mantha SN, Crowder DC, Chinchilla S, Shah KN, Yun YH, et al. Microstereolithography and characterization of poly(propylene fumarate)-based drug-loaded microneedle arrays. Biofabrication 2015;7:045001.
94. Luzuriaga MA, Berry DR, Reagan JC, Smaldone RA, Gassensmith JJ. Biodegradable 3D printed polymer microneedles for transdermal drug delivery. Lab Chip 2018;18:1223-30.
95. Pere CP, Economidou SN, Lall G, Ziraud C, Boateng JS, Alexander BD, et al. 3D printed microneedles for insulin skin delivery. Int J Pharm 2018;544:425-32.
96. Lim SH, Ng JY, Kang L. Three-dimensional printing of a microneedle array on personalized curved surfaces for dual-pronged treatment of trigger finger. Biofabrication 2017;9:015010.
97. Loo AH, Chua CK, Pumera M. DNA biosensing with 3D printing technology. Analyst 2017;142:279-83.
98. Araújo MR, Sa-Barreto LL, Gratieri T, Gelfuso GM, Cunha-Filho M. The digital pharmacies era: How 3D printing technology using fused deposition modeling can become a reality. Pharmaceutics 2019;11:128.
99. Khoo ZX, Teoh JE, Liu Y, Chua CK, Yang S, An J, et al. 3D printing of smart materials: A review on recent progresses in 4D printing. Virtual Phys Prototyp 2015;10:103-22.
100.Mitchell A, Lafont U, Ho?y?ska M, Semprimoschnig C. Additive manufacturing-a review of 4D printing and future applications. Addit Manuf 2018;24:606-26.
148 Views | 188 Downloads
How to Cite
NANDI, S. “3D PRINTING OF PHARMACEUTICALS – LEADING TREND IN PHARMACEUTICAL INDUSTRY AND FUTURE PERSPECTIVES”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 13, no. 12, Dec. 2020, pp. 10-16, doi:10.22159/ajpcr.2020.v13i12.39584.
Review Article(s)